GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Makers Laboratories Ltd-$
Standalone and Consolidated Financial Results for FY 25-26
RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 26 May 2026, 12:50 PM IST  ·  BSE ID: d6831df6-bd6d-450b-91ef-d148128d0b34
View Original BSE Filing (PDF)
⚡ Quick Answer
Makers Laboratories Limited reported a standalone net loss of Rs. 171.98 Lacs for the financial year ended March 31, 2026. Despite a loss, revenue from operations for FY26 rose to Rs. 5,034.73 Lacs. Total income for the period was Rs. 5,094.01 Lacs, with expenses reaching Rs. 5,295.14 Lacs. The company received an unmodified audit opinion on its financial statements.
💡
In Simple Terms
The company reported a net loss for the year, even as its main business revenue saw an increase.
🤖 AI Summary
  • Makers Laboratories Limited reported a standalone net loss of Rs. 171.98 Lacs for the financial year ended March 31, 2026.
  • Revenue from operations increased to Rs. 5,034.73 Lacs for FY26, compared to Rs. 4,294.46 Lacs in FY25.
  • Total income for the financial year ended March 31, 2026, was Rs. 5,094.01 Lacs.
  • The Board of Directors approved the audited standalone and consolidated financial results with an unmodified audit opinion.
  • Basic & Diluted Earnings per share for FY26 was (2.91) (of Rs.10/- each), down from 7.87 in FY25.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (FY26)
5,034.73 Lacs
17.24%
Net Profit/(Loss) for the period (FY26)
(171.98) Lacs
Total Income (FY26)
5,094.01 Lacs
Total Expenses (FY26)
5,295.14 Lacs
8.20%
Other Income (FY26)
59.28 Lacs
🏢 How This Affects the Company
📈
Business Impact
Revenue from operations for the pharmaceuticals segment increased, indicating growth in core business activities, despite overall financial loss.
💰
Financial Impact
The company recorded a net loss of Rs. 171.98 Lacs for FY26, a decline from a net profit of Rs. 464.11 Lacs in FY25. Total expenses rose to Rs. 5,295.14 Lacs in FY26 from Rs. 4,893.95 Lacs in FY25.
⚙️
Operational Impact
The company evaluated the implication of new labor codes on employee benefits, resulting in an incremental impact of Rs. 10.92 Lacs charged to the profit and loss statement.
⚠️
Risk Impact
The substantial decline from profit to net loss for the full financial year indicates a financial performance shift, requiring closer examination of expense management and other income components.
👥 What This Means For Shareholders
Action Required
No specific action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the shift from a net profit of Rs. 464.11 Lacs in FY25 to a net loss of Rs. 171.98 Lacs in FY26.
🔍
Management Signal
The management's declaration of an unmodified audit opinion signals adherence to accounting standards despite the reported net loss.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 results — monitor for trends in revenue and expense management
Company announcements — check for strategic initiatives to restore profitability
Detailed annual report — review in-depth financial disclosures and management commentary
MEDIUM RISK Shift from profit to net loss for the full year and dependency on non-recurring 'Other Income' in the prior year are notable.
💡 Investor Takeaway
Makers Laboratories Limited reported a standalone net loss of Rs. 171.98 Lacs for FY26, a decline from Rs. 464.11 Lacs profit in FY25. Revenue from operations increased to Rs. 5,034.73 Lacs in FY26. Other Income was significantly lower at Rs. 59.28 Lacs due to non-recurring gains in the prior year.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from operations increased by 17.24% to Rs. 5,034.73 Lacs in FY26 from Rs. 4,294.46 Lacs in FY25, showing core business growth.
  • The audit reports on both standalone and consolidated financial results for FY26 received an unmodified opinion, indicating financial transparency.

⚠️ Concerns

  • The company reported a net loss of Rs. 171.98 Lacs in FY26, a significant decline from a net profit of Rs. 464.11 Lacs in FY25.
  • Other income decreased significantly to Rs. 59.28 Lacs in FY26 from Rs. 1,092.35 Lacs in FY25, notably due to a large profit on asset sale in the prior year.
❓ Frequently Asked Questions
What was Makers Laboratories Ltd's net profit/loss for the financial year ended March 31, 2026?
Makers Laboratories Ltd reported a standalone net loss of Rs. 171.98 Lacs for the financial year ended March 31, 2026.
What was the revenue from operations for Makers Laboratories Ltd in FY26?
Revenue from operations for Makers Laboratories Ltd was Rs. 5,034.73 Lacs for FY26.
What was the total income of Makers Laboratories Ltd in FY26?
Makers Laboratories Ltd reported a total income of Rs. 5,094.01 Lacs for the financial year 2026.
What were the total expenses for Makers Laboratories Ltd in FY26?
Makers Laboratories Ltd's total expenses for the financial year 2026 amounted to Rs. 5,295.14 Lacs.
Did Makers Laboratories Ltd receive an audit qualification for FY26 results?
No, Makers Laboratories Ltd received an unmodified audit opinion on its financial results for FY26.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.